Investigation on Klebsiella pneumoniae in the field of extracellular vesicles
Junwei Wu , Yuheng Liu , Jin Su , Yi Yang , Haiyi Deng , Yilin Yang , Mengxi Yanglan , Xinyi Wu , Shiqi Luo , Yao Liao , Lifu Wang
Interdisciplinary Medicine ›› 2025, Vol. 3 ›› Issue (4) : e20240081
Investigation on Klebsiella pneumoniae in the field of extracellular vesicles
Klebsiella pneumoniae (KP), recognized for its pronounced antibiotic resistance, is a prevalent agent of nosocomial infections such as hospital-acquired pneumonia. The alarming rate of serious infections and associated mortality renders KP a significant public health threat. Extracellular vesicles (EVs) are pivotal in KP's physiological and pathological mechanisms, facilitating material and information transfer and mediating interactions between the bacteria and the host. The critical role of EVs enhances our understanding of KP pathophysiology, disease progression, and strategies for infection control. This review emphasizes the mechanics of KP's antibiotic resistance and the instrumental role of EVs in the bacterium-host interplay, proposing EVs as a promising research focus for advancing KP diagnosis, therapy, and prevention.
antibiotic resistance / extracellular vesicles / Klebsiella pneumoniae / pneumonia / vaccines / virulence
| [1] |
|
| [2] |
|
| [3] |
CHINET, National Bacterial Drug Resistance Surveillance Report 2022 (Brief Version) 2023, https://www.carss.cn/Report/Details/917 |
| [4] |
|
| [5] |
|
| [6] |
|
| [7] |
|
| [8] |
|
| [9] |
WHO, Antimicrobial Resistance 2023, https://www.who.int/news-room/fact-sheets/detail/antimicrobial-resistance |
| [10] |
WHO, Antimicrobial Resistance, Hypervirulent Klebsiella pneumoniae - Global Situation 2024, https://www.who.int/emergencies/disease-outbreak-news/item/2024-DON527 |
| [11] |
|
| [12] |
|
| [13] |
|
| [14] |
|
| [15] |
|
| [16] |
|
| [17] |
|
| [18] |
|
| [19] |
|
| [20] |
|
| [21] |
|
| [22] |
|
| [23] |
WHO, WHO Bacterial Priority Pathogens List, 2024 2024, https://www.who.int/news/item/17-05-2024-who-updates-list-of-drug-resistant-bacteria-most-threatening-to-human-health |
| [24] |
WHO, SAGE Updates COVID-19 Vaccination Guidance 2023, https://www.who.int/news/item/28-03-2023-sage-updates-covid-19-vaccination-guidance |
| [25] |
WHO, Better Use of Vaccines Could Reduce Antibiotic Use by 2.5 Billion Doses Annually, Says WHO 2024, https://www.who.int/news/item/10-10-2024-better-use-of-vaccines-could-reduce-antibiotic-use-by-2.5-billion-doses-annually--says-who |
| [26] |
|
| [27] |
|
| [28] |
|
| [29] |
WHO, Report Signals Increasing Resistance to Antibiotics in Bacterial Infections in Humans and Need for Better Data 2023, https://www.who.int/news/item/09-12-2022-report-signals-increasing-resistance-to-antibiotics-in-bacterial-infections-in-humans-and-need-for-better-data |
| [30] |
|
| [31] |
|
| [32] |
WHO, Lack of New Antibiotics Threatens Global Efforts to Contain Drug-Resistant Infections 2020, https://www.who.int/news/item/17-01-2020-lack-of-new-antibiotics-threatens-global-efforts-to-contain-drug-resistant-infections |
| [33] |
|
| [34] |
|
| [35] |
|
| [36] |
|
| [37] |
|
| [38] |
|
| [39] |
|
| [40] |
|
| [41] |
|
| [42] |
|
| [43] |
|
| [44] |
|
| [45] |
|
| [46] |
|
| [47] |
|
| [48] |
|
| [49] |
|
| [50] |
|
| [51] |
|
| [52] |
|
| [53] |
|
| [54] |
|
| [55] |
|
| [56] |
|
| [57] |
|
| [58] |
|
| [59] |
|
| [60] |
|
| [61] |
|
| [62] |
|
| [63] |
|
| [64] |
|
| [65] |
|
| [66] |
|
| [67] |
|
| [68] |
|
| [69] |
|
| [70] |
|
| [71] |
|
| [72] |
|
| [73] |
|
| [74] |
|
| [75] |
|
| [76] |
|
| [77] |
|
| [78] |
|
| [79] |
|
| [80] |
|
| [81] |
|
| [82] |
|
| [83] |
|
| [84] |
|
| [85] |
|
| [86] |
|
| [87] |
|
| [88] |
|
| [89] |
|
| [90] |
|
| [91] |
|
| [92] |
|
| [93] |
|
| [94] |
|
| [95] |
|
| [96] |
|
| [97] |
|
| [98] |
|
| [99] |
|
| [100] |
|
| [101] |
|
| [102] |
|
| [103] |
|
| [104] |
|
| [105] |
|
| [106] |
|
| [107] |
|
| [108] |
|
| [109] |
|
| [110] |
|
| [111] |
|
| [112] |
|
| [113] |
|
| [114] |
|
| [115] |
|
| [116] |
|
| [117] |
|
| [118] |
|
| [119] |
|
| [120] |
|
| [121] |
|
| [122] |
|
| [123] |
|
| [124] |
|
| [125] |
|
| [126] |
|
2025 The Author(s). Interdisciplinary Medicine published by Wiley-VCH GmbH on behalf of Nanfang Hospital, Southern Medical University.
/
| 〈 |
|
〉 |